Quality control outcomes analysis of small-incision lenticule extraction for myopia by a novice surgeon at the first refractive surgery unit in Nepal during the first 2 years of operation
详细信息    查看全文
文摘
To evaluate the outcomes of small-incision lenticule extraction for myopia using the Visumax femtosecond laser at the first refractive surgery unit in Nepal during the first 30 months of operation.

id="absSec_2">Setting

id="abspara0015">Tilganga Institute of Ophthalmology, Kathmandu, Nepal.

id="absSec_3">Design

id="abspara0020">Retrospective noncomparative case series.

id="absSec_4">Methods

id="abspara0025">Consecutive myopic small-incision lenticule extraction procedures by a fellowship-trained surgeon were evaluated. Inclusion criteria were a preoperative spherical equivalent (SE) refraction up to −10.00 diopters (D) and corrected distance visual acuity (CDVA) of 20/20 or better. Outcomes analysis using the Standard Graphs for Reporting Refractive Surgery was performed over a 3-month follow-up.

id="absSec_5">Results

id="abspara0030">Three-month data were available for 1396 eyes. The mean attempted SE was &minus;5.78 D ± 1.81 (SD) (range &minus;0.96 to &minus;10.00 D) and the mean cylinder, 0.79 ± 0.69 D (range 0.00 to 5.25 D). Postoperatively, the mean SE relative to target was &minus;0.28 ± 0.29 D (range &minus;1.31 to +1.50 D) and was within ±0.50 D in 80% of eyes and ±1.00 D in 99% of eyes. The uncorrected distance visual acuity was 20/20 or better in 95% of eyes and 20/25 or better in 99% of eyes. One line of CDVA was lost in 2% of eyes; no eye lost 2 or more lines. There was a small improvement in contrast sensitivity (P < .01).

id="absSec_6">Conclusions

id="abspara0035">The outcomes of myopic small-incision lenticule extraction up to &minus;10.00 D performed at the first refractive surgery unit in Nepal by a fellowship-trained surgeon with no corneal refractive surgery experience were as safe and effective as outcomes in previous studies.

id="absSec_7">Financial Disclosure

id="abspara0040">Dr. Reinstein is a consultant to Carl Zeiss Meditec AG and has a proprietary interest in the Artemis technology (Arcscan, Inc.) through patents administered by the Center for Technology Licensing at Cornell University, Ithaca, New York, USA. Drs. Pradhan and Carp have travel expenses to conferences paid by Carl Zeiss Meditec AG. No other author has a financial or proprietary interest in any material or method mentioned.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700